Asia Pacific Artesunate Market Size & Outlook, 2026-2034


Asia Pacific Artesunate Market Insights

  • Reed Intelligence analysis indicates that the Asia Pacific Artesunate Market size, which was USD 80.5 Million in 2025, is projected to attain USD 148.71 Million by 2034.
  • The market is expected to register a CAGR of 7% over the period 2026–2034.
  • In 2025, Injectable Artesunate emerged as the dominant Formulation based on market size.
  • Injectable Artesunate is projected to register the fastest growth, positioning it as the most attractive Formulation segment over the forecast horizon.

Other Key Findings


  • In 2025, Asia Pacific contributed 15.48% to the overall global Artesunate Market size.
  • By 2034, United States is anticipated to dominate the global market based on market size.
  • China is expected to witness the fastest growth within Asia Pacific, attaining USD 62.29 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 80.5 Million
Market Size In 2034 USD 148.71 Million
Largest segment Injectable Artesunate
Units Revenue in USD Million
CAGR 7% (2026-2034)
Segmnetation Covered
Asia Pacific
  1. China
  2. India
  3. Japan
  4. South Korea
  5. Taiwan
  6. Australia
  7. Singapore
  8. South East Asia
Formulation
  1. Injectable Artesunate
  2. Oral Artesunate
Application
  1. Severe Malaria Treatment
  2. Uncomplicated Malaria Treatment
End-Use
  1. Hospitals
  2. Clinics
  3. Retail Pharmacies
Distribution Channel
  1. Government Supply Programs
  2. Private Sector Distribution
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends